Nike remains in a multi-year slump, but UBS survey data point to improving brand strength, rising loyalty, and better product availability. Analysts see a turnaround forming, though slower than markets expect amid China weakness and mixed demand.

Overmedication among U.S. seniors is rising, with millions taking multiple prescriptions and facing dangerous side effects. As healthcare risks grow and Social Security cuts loom, physical health and financial resilience are becoming critical.

A breadth-driven technical outlook shows the Nasdaq 100 and broader U.S. equities holding long-term bullish trends into 2026, with gold gaining strength but still facing major resistance relative to stocks.

The Solana ecosystem is facing fresh turbulence after USX stablecoin, a synthetic stablecoin issued by Solstice, suffered a sharp but temporary depeg on secondary markets.